nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Uveitis—Ritonavir—acquired immunodeficiency syndrome	0.0246	0.0246	CcSEcCtD
Metipranolol—Blepharitis—Delavirdine—acquired immunodeficiency syndrome	0.0151	0.0151	CcSEcCtD
Metipranolol—Blepharitis—Ritonavir—acquired immunodeficiency syndrome	0.014	0.014	CcSEcCtD
Metipranolol—Blepharitis—Saquinavir—acquired immunodeficiency syndrome	0.0134	0.0134	CcSEcCtD
Metipranolol—Photophobia—Zidovudine—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Metipranolol—Arthritis—Nelfinavir—acquired immunodeficiency syndrome	0.00953	0.00953	CcSEcCtD
Metipranolol—Acute coronary syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00886	0.00886	CcSEcCtD
Metipranolol—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.00881	0.00881	CcSEcCtD
Metipranolol—Photophobia—Delavirdine—acquired immunodeficiency syndrome	0.00872	0.00872	CcSEcCtD
Metipranolol—Abnormal vision—Efavirenz—acquired immunodeficiency syndrome	0.00847	0.00847	CcSEcCtD
Metipranolol—Photophobia—Ritonavir—acquired immunodeficiency syndrome	0.00807	0.00807	CcSEcCtD
Metipranolol—Bronchitis—Stavudine—acquired immunodeficiency syndrome	0.00767	0.00767	CcSEcCtD
Metipranolol—Bronchitis—Abacavir—acquired immunodeficiency syndrome	0.00756	0.00756	CcSEcCtD
Metipranolol—Abnormal vision—Ritonavir—acquired immunodeficiency syndrome	0.00749	0.00749	CcSEcCtD
Metipranolol—Photophobia—Lamivudine—acquired immunodeficiency syndrome	0.00741	0.00741	CcSEcCtD
Metipranolol—Conjunctivitis—Nevirapine—acquired immunodeficiency syndrome	0.00716	0.00716	CcSEcCtD
Metipranolol—Arthritis—Delavirdine—acquired immunodeficiency syndrome	0.00694	0.00694	CcSEcCtD
Metipranolol—Conjunctivitis—Stavudine—acquired immunodeficiency syndrome	0.00691	0.00691	CcSEcCtD
Metipranolol—Acute coronary syndrome—Abacavir—acquired immunodeficiency syndrome	0.00691	0.00691	CcSEcCtD
Metipranolol—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.00687	0.00687	CcSEcCtD
Metipranolol—Conjunctivitis—Abacavir—acquired immunodeficiency syndrome	0.00681	0.00681	CcSEcCtD
Metipranolol—Epistaxis—Nelfinavir—acquired immunodeficiency syndrome	0.00673	0.00673	CcSEcCtD
Metipranolol—Rhinitis—Nelfinavir—acquired immunodeficiency syndrome	0.00642	0.00642	CcSEcCtD
Metipranolol—Arthritis—Ritonavir—acquired immunodeficiency syndrome	0.00642	0.00642	CcSEcCtD
Metipranolol—Rhinitis—Stavudine—acquired immunodeficiency syndrome	0.0064	0.0064	CcSEcCtD
Metipranolol—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00628	0.00628	CcSEcCtD
Metipranolol—Arthritis—Saquinavir—acquired immunodeficiency syndrome	0.00618	0.00618	CcSEcCtD
Metipranolol—Myalgia—Amprenavir—acquired immunodeficiency syndrome	0.00598	0.00598	CcSEcCtD
Metipranolol—Discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00591	0.00591	CcSEcCtD
Metipranolol—Epistaxis—Zidovudine—acquired immunodeficiency syndrome	0.00583	0.00583	CcSEcCtD
Metipranolol—Acute coronary syndrome—Indinavir—acquired immunodeficiency syndrome	0.00567	0.00567	CcSEcCtD
Metipranolol—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.00564	0.00564	CcSEcCtD
Metipranolol—Bronchitis—Delavirdine—acquired immunodeficiency syndrome	0.00561	0.00561	CcSEcCtD
Metipranolol—Rhinitis—Zidovudine—acquired immunodeficiency syndrome	0.00556	0.00556	CcSEcCtD
Metipranolol—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.00545	0.00545	CcSEcCtD
Metipranolol—Discomfort—Didanosine—acquired immunodeficiency syndrome	0.00539	0.00539	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00522	0.00522	CcSEcCtD
Metipranolol—Bronchitis—Ritonavir—acquired immunodeficiency syndrome	0.00518	0.00518	CcSEcCtD
Metipranolol—Conjunctivitis—Delavirdine—acquired immunodeficiency syndrome	0.00505	0.00505	CcSEcCtD
Metipranolol—Bronchitis—Saquinavir—acquired immunodeficiency syndrome	0.00499	0.00499	CcSEcCtD
Metipranolol—Epistaxis—Delavirdine—acquired immunodeficiency syndrome	0.0049	0.0049	CcSEcCtD
Metipranolol—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.0049	0.0049	CcSEcCtD
Metipranolol—Rhinitis—Efavirenz—acquired immunodeficiency syndrome	0.00489	0.00489	CcSEcCtD
Metipranolol—Cough—Stavudine—acquired immunodeficiency syndrome	0.00485	0.00485	CcSEcCtD
Metipranolol—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00484	0.00484	CcSEcCtD
Metipranolol—Cough—Abacavir—acquired immunodeficiency syndrome	0.00478	0.00478	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00476	0.00476	CcSEcCtD
Metipranolol—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.00476	0.00476	CcSEcCtD
Metipranolol—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00475	0.00475	CcSEcCtD
Metipranolol—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.00475	0.00475	CcSEcCtD
Metipranolol—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Metipranolol—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Metipranolol—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00473	0.00473	CcSEcCtD
Metipranolol—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00473	0.00473	CcSEcCtD
Metipranolol—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00472	0.00472	CcSEcCtD
Metipranolol—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.00471	0.00471	CcSEcCtD
Metipranolol—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.0047	0.0047	CcSEcCtD
Metipranolol—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.0047	0.0047	CcSEcCtD
Metipranolol—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.00469	0.00469	CcSEcCtD
Metipranolol—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00469	0.00469	CcSEcCtD
Metipranolol—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.00468	0.00468	CcSEcCtD
Metipranolol—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.00467	CcSEcCtD
Metipranolol—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.00466	0.00466	CcSEcCtD
Metipranolol—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00465	0.00465	CcSEcCtD
Metipranolol—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.00461	0.00461	CcSEcCtD
Metipranolol—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00455	0.00455	CcSEcCtD
Metipranolol—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.00453	0.00453	CcSEcCtD
Metipranolol—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.0045	0.0045	CcSEcCtD
Metipranolol—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00447	0.00447	CcSEcCtD
Metipranolol—Tension—Indinavir—acquired immunodeficiency syndrome	0.00441	0.00441	CcSEcCtD
Metipranolol—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00436	0.00436	CcSEcCtD
Metipranolol—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.00436	0.00436	CcSEcCtD
Metipranolol—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00433	0.00433	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00428	0.00428	CcSEcCtD
Metipranolol—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00423	0.00423	CcSEcCtD
Metipranolol—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00422	0.00422	CcSEcCtD
Metipranolol—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Metipranolol—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00417	0.00417	CcSEcCtD
Metipranolol—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00416	0.00416	CcSEcCtD
Metipranolol—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.00416	0.00416	CcSEcCtD
Metipranolol—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00416	0.00416	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00415	0.00415	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00413	0.00413	CcSEcCtD
Metipranolol—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00412	0.00412	CcSEcCtD
Metipranolol—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Metipranolol—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Metipranolol—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.0041	0.0041	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00407	0.00407	CcSEcCtD
Metipranolol—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Metipranolol—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Metipranolol—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00405	0.00405	CcSEcCtD
Metipranolol—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00403	0.00403	CcSEcCtD
Metipranolol—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Metipranolol—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Metipranolol—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Metipranolol—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Metipranolol—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00397	0.00397	CcSEcCtD
Metipranolol—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00397	0.00397	CcSEcCtD
Metipranolol—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Metipranolol—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Metipranolol—Cough—Indinavir—acquired immunodeficiency syndrome	0.00392	0.00392	CcSEcCtD
Metipranolol—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00385	0.00385	CcSEcCtD
Metipranolol—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00383	0.00383	CcSEcCtD
Metipranolol—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00383	0.00383	CcSEcCtD
Metipranolol—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00381	0.00381	CcSEcCtD
Metipranolol—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00378	0.00378	CcSEcCtD
Metipranolol—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Metipranolol—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Metipranolol—Cough—Efavirenz—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Metipranolol—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Metipranolol—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Metipranolol—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Metipranolol—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Metipranolol—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Metipranolol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Metipranolol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Metipranolol—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.0036	0.0036	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Metipranolol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Metipranolol—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Metipranolol—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00357	0.00357	CcSEcCtD
Metipranolol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00354	0.00354	CcSEcCtD
Metipranolol—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00354	0.00354	CcSEcCtD
Metipranolol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00352	0.00352	CcSEcCtD
Metipranolol—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Metipranolol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Metipranolol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00346	0.00346	CcSEcCtD
Metipranolol—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00346	0.00346	CcSEcCtD
Metipranolol—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Metipranolol—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Metipranolol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0034	0.0034	CcSEcCtD
Metipranolol—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00338	0.00338	CcSEcCtD
Metipranolol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Metipranolol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Metipranolol—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Metipranolol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00334	0.00334	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00334	0.00334	CcSEcCtD
Metipranolol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00332	0.00332	CcSEcCtD
Metipranolol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Metipranolol—Rash—Didanosine—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Metipranolol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Metipranolol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Metipranolol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00328	0.00328	CcSEcCtD
Metipranolol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00327	0.00327	CcSEcCtD
Metipranolol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00327	0.00327	CcSEcCtD
Metipranolol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Metipranolol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Metipranolol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Metipranolol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Metipranolol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Metipranolol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Metipranolol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Metipranolol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Metipranolol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00315	0.00315	CcSEcCtD
Metipranolol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00312	0.00312	CcSEcCtD
Metipranolol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Metipranolol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00309	0.00309	CcSEcCtD
Metipranolol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00308	0.00308	CcSEcCtD
Metipranolol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00308	0.00308	CcSEcCtD
Metipranolol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Metipranolol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Metipranolol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Metipranolol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Metipranolol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Metipranolol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Metipranolol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Metipranolol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Metipranolol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Metipranolol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Metipranolol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Metipranolol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Metipranolol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Metipranolol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Metipranolol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Metipranolol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.0029	0.0029	CcSEcCtD
Metipranolol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Metipranolol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Metipranolol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00286	0.00286	CcSEcCtD
Metipranolol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00286	0.00286	CcSEcCtD
Metipranolol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00285	0.00285	CcSEcCtD
Metipranolol—Headache—Stavudine—acquired immunodeficiency syndrome	0.00284	0.00284	CcSEcCtD
Metipranolol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Metipranolol—Rash—Abacavir—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Metipranolol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Metipranolol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Metipranolol—Headache—Abacavir—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00279	0.00279	CcSEcCtD
Metipranolol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00279	0.00279	CcSEcCtD
Metipranolol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Metipranolol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Metipranolol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Metipranolol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Metipranolol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Metipranolol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Metipranolol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Metipranolol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Metipranolol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00262	0.00262	CcSEcCtD
Metipranolol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00261	0.00261	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Metipranolol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Metipranolol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Metipranolol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Metipranolol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Metipranolol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Metipranolol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Metipranolol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00247	0.00247	CcSEcCtD
Metipranolol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Metipranolol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Metipranolol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Metipranolol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00234	0.00234	CcSEcCtD
Metipranolol—Rash—Indinavir—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Metipranolol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Metipranolol—Headache—Indinavir—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Metipranolol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Metipranolol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Metipranolol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.0022	CcSEcCtD
Metipranolol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Metipranolol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00218	0.00218	CcSEcCtD
Metipranolol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00218	0.00218	CcSEcCtD
Metipranolol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00218	0.00218	CcSEcCtD
Metipranolol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00217	CcSEcCtD
Metipranolol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00217	0.00217	CcSEcCtD
Metipranolol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
Metipranolol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00209	0.00209	CcSEcCtD
Metipranolol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00209	0.00209	CcSEcCtD
Metipranolol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Metipranolol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00207	CcSEcCtD
Metipranolol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Metipranolol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00203	CcSEcCtD
Metipranolol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00202	0.00202	CcSEcCtD
Metipranolol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Metipranolol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00195	CcSEcCtD
Metipranolol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Metipranolol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Metipranolol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Metipranolol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Metipranolol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Metipranolol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Metipranolol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Metipranolol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Metipranolol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00177	0.00177	CcSEcCtD
Metipranolol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00177	0.00177	CcSEcCtD
Metipranolol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Metipranolol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Metipranolol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
